ABCSG 55N / AMBHER Overview
Description of patients with HER2 positive breast cancer undergoing neoadjuvant treatment and development of a dynamic composite risk score to predict the risk of distant recurrence
| Study Start: | FPI 03/2023 |
| Coordinating Investigator: | Marija Balic, Graz |
| Sample Size:: | AT: 500 |
| Study Design: (Click to enlarge) |
 |
Share on